An annual booster dose of the coronavirus vaccine, which will also provide protection against influenza and respiratory syncytial virus (RSV), has been announced by Moderna.
The pharmaceutical company stressed that the “three in one” vaccine will be constantly modified for new mutations in the coronavirus.
“A pillar of Moderna’s product strategy is the development of an annual booster vaccine, which the company plans to continually adapt. The company believes it could be the first on the market with a booster vaccine against COVID + Influenza + RSV.” .
As Moderna CEO Stephan Bancell points out, “even before the pandemic, about three million people died each year from respiratory infections. Our goal is to reduce those numbers with an annual booster vaccine.”
One pillar of our product strategy is to develop a pan-respiratory annual #booster #vaccine, which we plan to continuously customize. We believe that we could be first to market with a COVID + #Flu + #RSV booster vaccine. https://t.co/RXnx5k57hC
– Modern (@moderna_tx) December 10, 2021
Earlier, Moderna announced the first data for its flu vaccine based on mRNA technology, according to which “it may not be strong enough to give an advantage over the already approved flu vaccines on the market, especially for the elderly”.
The company said in a presentation to investors that its antibody levels against all four strains of the flu virus in an early-stage study were not as strong in older adults as Sanofi’s Fluzone HD.
“On the one hand, the antibodies have risen to good levels, but on the other hand the levels are not necessarily considered as high or necessarily better than some highly effective vaccines, such as Flublok or Fluzone HD,” said Jefferies analyst Michael Yee. in a note to her clients.
The candidate vaccine, mRNA-1010, is based on mRNA technology, which is also used in COVID-19 vaccines.
Moderna shares fell 10% on Friday.
Read also:
* Moderna: Shares fall despite encouraging results for flu vaccine
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
